Showing results (451-460 of 948) with videos related to
Sort By:
Pageof 95
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2008
Peptidoglycan recognition protein-SD provides versatility of receptor formation in Drosophila immunityLihui Wang, Robert J C Gilbert, Magda L Atilano, et al.Molecular Biosystems|June 11, 2016
Histidine switch controlling pH-dependent protein folding and DNA binding in a transcription factor at the core of synthetic network devicesD K Deochand, I C Perera, R B Crochet, et al.Clinical Pediatrics|June 1, 1999
Follow-up imaging studies in children with splenic injuriesS Shafi, J C Gilbert, M S Irish, et al.Gastroenterologie Clinique Et Biologique|January 1, 1996
[Digestive involvement in dystrophic bullous epidermolysis. Presentation of 2 cases and review of the literature]M P Cocciale, C Gilbert, S Gogolewski, et al.The Journal of Pathology|October 8, 2008
Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescentsD C Gilbert, I Chandler, A McIntyre, et al.Nucleic Acids Research|February 26, 2015
Structural plasticity of Cid1 provides a basis for its distributive RNA terminal uridylyl transferase activityLuke A Yates, Benjamin P Durrant, Sophie Fleurdépine, et al.Journal of Virology|July 15, 2011
Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivoC Cubillos-Zapata, E Guzman, A Turner, et al.Bone Marrow Transplantation|August 5, 2000
Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantationB Bolwell, J Vredenburgh, B Overmoyer, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1994
Lifestyle factors and bone density in the elderly: implications for osteoporosis preventionT V Nguyen, P J Kelly, P N Sambrook, et al.BMJ Oncology|January 31, 2025
Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid reviewHannah Louise Bromley, Mohini Varughese, Duncan C Gilbert, et al.Pageof 95